技術賦能的三大變革：

The three major changes empowered by technology:

智能篩查設備升級：

Upgrade of intelligent screening equipment:

新型 AI 乳腺超聲設備（如聯影 uAI-Breast）通過三維重建技術，將乳腺結節檢出率提升至 98.7%，較傳統超聲提高 12%。

The new AI breast ultrasound equipment (such as the United Imaging uAI Breast) has increased the detection rate of breast nodules to 98.7% through 3D reconstruction technology, which is 12% higher than traditional ultrasound.

宮頸癌篩查領域，華大基因的 HPV 檢測試劑盒實現 28 種高危型分型，靈敏度達 99.6%，較傳統方法縮短檢測時間至 4 小時。

In the field of cervical cancer screening, BGI Genomics' HPV testing kit achieves typing of 28 high-risk types with a sensitivity of 99.6%, shortening the detection time to 4 hours compared to traditional methods.

數據驅動的精準防控：

Data driven precision prevention and control:

國家癌癥中心構建的 “兩癌篩查大數據平臺” 整合全國 2.3 億份篩查數據，通過機器學習建立風險預測模型，將乳腺癌風險評估準確率提升至 89%，宮頸癌風險預警提前量達 3 年。

The "Big Data Platform for Two Cancer Screening" built by the National Cancer Center integrates 230 million screening data across the country, builds a risk prediction model through machine learning, improves the accuracy of breast cancer risk assessment to 89%, and advances cervical cancer risk early warning by three years.

上海、深圳等地試點 “AI 輔助診斷云平臺”，基層醫院將宮頸細胞涂片上傳云端，AI 系統 5 分鐘內生成診斷報告，基層診斷符合率從 65% 提升至 92%。

Shanghai, Shenzhen and other places are piloting the "AI assisted diagnosis cloud platform". Primary hospitals upload cervical cell smears to the cloud, and the AI system generates diagnostic reports within 5 minutes. The primary diagnosis compliance rate has increased from 65% to 92%.

服務模式創新：

Service model innovation:

廣西恭城縣推行 “一站式篩查服務”，將原本分散在 5 個科室的流程整合為 “登記 - 采樣 - 檢查 - 報告” 四步，篩查效率提升 3 倍。

Gongcheng County in Guangxi Province has implemented a "one-stop screening service", integrating the previously scattered process of five departments into four steps of "registration sampling inspection reporting", which has increased screening efficiency by three times.

福州倉山區開發 “兩癌篩查小程序”，實現線上預約、結果查詢、隨訪提醒全流程數字化，患者滿意度達 95%。

Fuzhou Cangshan District has developed a "two cancer screening mini program" to digitize the entire process of online appointment, result query, and follow-up reminder, with a patient satisfaction rate of 95%.

未來圖景：從 “疾病篩查” 到 “健康管理”

Future vision: from "disease screening" to "health management"

1. 多癌種聯合篩查：

1. Multi cancer combined screening:

國家癌癥中心啟動 “泛癌早篩計劃”，通過血液檢測同時篩查宮頸癌、乳腺癌、肺癌等 8 種癌癥，2025 年試點數據顯示，早期癌癥檢出率提升至 65%。

The National Cancer Center launched the "pan cancer early screening program" to screen eight cancers, including cervical cancer, breast cancer and lung cancer, through blood testing. The pilot data in 2025 shows that the detection rate of early cancer has increased to 65%.

2. 個性化健康干預：

2. Personalized health intervention:

阿里健康開發 “女性健康數字孿生系統”，通過分析遺傳、生活方式、環境等數據，為每位女性生成個性化篩查方案。例如，對攜帶 BRCA1 突變的女性，系統建議從 25 歲開始每年進行乳腺 MRI 檢查。

Alibaba Health has developed the 'Women's Health Digital Twin System', which generates personalized screening plans for each woman by analyzing genetic, lifestyle, environmental, and other data. For example, for women carrying BRCA1 mutations, the system recommends annual breast MRI examinations starting from the age of 25.

3. 醫療資源下沉：

3. Sinking of medical resources:

華為云聯合基層醫院部署 “5G+AI 篩查站”，通過遠程超聲機器人和 AI 診斷系統，使偏遠地區患者可享受三甲醫院級篩查服務。2025 年試點區域篩查覆蓋率提升至 95%，陽性病例漏診率下降至 0.8%。

Huawei Cloud collaborates with grassroots hospitals to deploy "5G+AI screening stations", which enable remote patients to enjoy tertiary hospital level screening services through remote ultrasound robots and AI diagnostic systems. By 2025, the screening coverage rate in pilot areas will be increased to 95%, and the missed diagnosis rate of positive cases will be reduced to 0.8%.

中國兩癌篩查系統的進化史，是一部科技賦能公共衛生的生動實踐。從 AI 輔助診斷到區塊鏈數據安全，從云端病理會診到 5G 遠程篩查，這些創新不僅提升了篩查效率，更重塑了醫療公平的邊界。當技術紅利真正惠及每一位女性，我們正在書寫的，不僅是疾病防控的新篇章，更是健康中國戰略最溫暖的注腳

The evolutionary history of China's two cancer screening systems is a vivid practice of technology empowering public health. From AI assisted diagnosis to blockchain data security, from cloud based pathology consultation to 5G remote screening, these innovations not only improve screening efficiency, but also reshape the boundaries of medical fairness. When the technological dividend truly benefits every woman, what we are writing is not only a new chapter in disease prevention and control, but also the warmest footnote to the Healthy China strategy

本文由兩癌篩查系統友情奉獻.更多有關的知識請點擊:http://m.d701.cn我們將會對您提出的疑問進行詳細的解答，歡迎您登錄網站留言.

This article is dedicated to friendship For more information, please click: We will provide detailed answers to your questions. You are welcome to log in to our website and leave a message